Cybeats Signs Commercial Agreement with a Top 3 Global Medical Device and Diagnostics Company

TORONTO, Jan. 20, 2023 /PRNewswire/ – Cybeats Technologies Corp. (“Cybeats” or the “Company”) (CSE: CYBT) is pleased to announce a new software license agreement with a top 3 global medical device and diagnostics leader, for Cybeats’ SBOM Studio1to manage their Software Bill of Materials (SBOM) and support regulatory compliance requirements with looming FDA mandates on … Read more